{"version":"1.0","type":"link","title":"PD-L1 expression combined with immune phenotype is a potential predictor of outcome with PD-1 inhibitor monotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.","author_name":"Kim DH 외","author_url":"https://prs-insight.online/author/Kim%20DH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/166734","thumbnail_width":1200,"thumbnail_height":630}